J. Wouter Jukema

Leiden University Medical Center

Netherlands

Research Interests

Explore related searches

Professors in Netherlands

Contact this professor

Get a free first email built on one of their papers, ready for you to edit and send yourself.

Articles (20)

Year:

2025

Year:

2025

Year:

2025

Year:

2025

Year:

2025

Year:

2025

Year:

2024

Year:

2024

Year:

2024

Year:

2024

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Year:

2022

Year:

2022

Collaborators (15)

Martin Giera

Assoc. Prof.

Universitair Medisch Centrum Utrecht

NETHERLANDS

View details

Lars Verschuren

TNO

NETHERLANDS

View details

Steven HJ Hageman

University Medical Center Groningen

NETHERLANDS

View details

José Inia

Netherlands Organisation for Applied Scientific Research

NETHERLANDS

View details

Ron Herings

Professor Pharmacoepidemiology & Health Optimization

NETHERLANDS

View details

Johan HC Reiber

Emeritus Prof

Leiden University Medical Center

NETHERLANDS

View details

Margreet de Vries

Leiden University Medical Center

NETHERLANDS

View details

Vera Bittner

The University of Alabama

UNITED STATES

View details

Paul H. A. Quax

Leiden University Medical Center

NETHERLANDS

View details

Deepak Bhatt

Director of Mount Sinai Heart and Dr. Valentin Fuster Professor of Cardiovascular Medicine

Icahn School of Medicine at Mount Sinai

UNITED STATES

View details

Philippe Gabriel Steg

FRANCE

View details

JAVIER BOTAS

Associate Professor

Universidad Rey Juan Carlos

SPAIN

View details

Elissa Polomski

Leiden University Medical Center

NETHERLANDS

View details

Juhani Knuuti

FINLAND

View details

Jesse Swen

Full professor of clinical pharmacy, in particular translational pharmacogenetics

Leiden University Medical Center

NETHERLANDS

View details

ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.

J. Wouter Jukema

Research Interests

Explore related searches

Contact this professor

Articles (20)

Multiplex Apolipoprotein Panel Improves Cardiovascular Event Prediction and Cardiovascular Outcome by Identifying Patients Who Benefit From Targeted PCSK9 Inhibitor Therapy

Relation of Low-Density Lipoprotein Cholesterol, High-Sensitivity C-Reactive Protein, and Lipoprotein(a) Each to Future Cardiovascular Events and Death After Acute Coronary Syndrome on High-Intensity Statin Therapy: An Analysis of the Placebo Arm of ODYSSEY OUTCOMES

Fibrogenic Gene Signature as Early Prediction for the Efficacy of Pharmacological Interventions for MASH‐Associated Fibrosis

Efficacy of a novel PCSK9 inhibitory peptide alone and with evinacumab in a mouse model of atherosclerosis

Pravastatin reduces all-cause mortality in elderly individuals at risk of liver fibrosis: Post hoc analysis of the PROSPER trial

Apolipoprotein C3 and risk of cardiovascular events and death in patients on optimized statin treatment after recent acute coronary syndrome

Estimating uncertainty when providing individual cardiovascular risk predictions: a Bayesian survival analysis

Therapeutic effects of FGF21 mimetic bFKB1 on MASH and atherosclerosis in Ldlr−/−.Leiden mice

Safety of the PCSK9 inhibitor alirocumab: insights from 47 296 patient-years of observation.

Comparison of left ventricular mass and wall thickness between cardiac computed tomography angiography and cardiac magnetic resonance imaging using machine learning algorithms

Feasibility of Community Pharmacist-Initiated and Point-of-Care CYP2C19 Genotype-Guided De-Escalation of Oral P2Y12 Inhibitors

Treatment and low-density lipoprotein cholesterol levels in patients with hypercholesterolaemia or mixed dyslipidaemia at high or very high cardiovascular risk: a population-based cross-sectional study in the Netherlands

Long‐Term Efficacy, Safety, and Tolerability of Alirocumab in 8242 Patients Eligible for 3 to 5 Years of Placebo‐Controlled Observation in the ODYSSEY OUTCOMES Trial

Relating Lipoprotein(a) Concentrations to Cardiovascular Event Risk After Acute Coronary Syndrome: A Comparison of Three Tests

Atorvastatin Attenuates Diet-Induced Non-Alcoholic Steatohepatitis in APOE*3-Leiden Mice by Reducing Hepatic Inflammation

Pericoronary Adipose Tissue Attenuation in Patients With Acute Coronary Syndrome Versus Stable Coronary Artery Disease

Valvular heart disease and cardiomyopathy: reappraisal of their interplay

Addressing current challenges in optimization of lipid management following an ACS event: Outcomes of the ACS EuroPath III initiative

Phosphorylcholine Monoclonal Antibody Therapy Decreases Intraplaque Angiogenesis and Intraplaque Hemorrhage in Murine Vein Grafts

Nuclear medicine imaging methods of radiation-induced cardiotoxicity

Collaborators (15)

Martin Giera

Lars Verschuren

Steven HJ Hageman

José Inia

Ron Herings

Johan HC Reiber

Margreet de Vries

Vera Bittner

Paul H. A. Quax

Deepak Bhatt

Philippe Gabriel Steg

JAVIER BOTAS

Elissa Polomski

Juhani Knuuti

Jesse Swen

Make your next move.